BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Budi HS, Ahmad FN, Achmad H, Ansari MJ, Mikhailova MV, Suksatan W, Chupradit S, Shomali N, Marofi F. Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02719-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Della Chiesa M, Setti C, Giordano C, Obino V, Greppi M, Pesce S, Marcenaro E, Rutigliani M, Provinciali N, Paleari L, Decensi A, Sivori S, Carlomagno S. NK Cell-Based Immunotherapy in Colorectal Cancer. Vaccines 2022;10:1033. [DOI: 10.3390/vaccines10071033] [Reference Citation Analysis]
2 Nikoo M, Rudiansyah M, Bokov DO, Jainakbaev NT, Suksatan W, Ansari MJ, Thangavelu L, Chupradit S, Zamani A, Adili A, Shomali N, Akbari M. Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances. J Cell Mol Med 2022. [PMID: 35762299 DOI: 10.1111/jcmm.17465] [Reference Citation Analysis]
3 Ahcene Djaballah S, Daniel F, Milani A, Ricagno G, Lonardi S. HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target. Am Soc Clin Oncol Educ Book 2022;42:1-14. [PMID: 35580290 DOI: 10.1200/EDBK_351354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Quinn S, Lenart N, Dronzek V, Scurti GM, Hossain NM, Nishimura MI. Genetic Modification of T Cells for the Immunotherapy of Cancer. Vaccines 2022;10:457. [DOI: 10.3390/vaccines10030457] [Reference Citation Analysis]